Suppr超能文献

链脲佐菌素诱导的糖尿病对大鼠肝脏糖基转移酶活性的影响。

The effects of streptozotocin diabetes on the activities of rat liver glycosyltransferases.

作者信息

Tepperman H M, DeWitt J, Tepperman J

出版信息

Diabetes. 1983 May;32(5):412-5. doi: 10.2337/diab.32.5.412.

Abstract

The effects of streptozotocin diabetes on the activities of rat liver glycosyltransferase enzymes have been investigated. Liver microsomal fractions were prepared from rats that had been injected with streptozotocin (65 mg/kg, i.v.) 3 wk to 2 mo earlier. Preparations from diabetic rats had decreased activities of N-acetylglucosaminyl transferase compared with those of age-matched controls (0.98 +/- 0.11 nmol transferred per mg protein in 30 min versus 3.19 +/- 0.34 for controls, P less than 0.001). Galactosyltransferase activity was also lower in diabetic rat livers (1.48 +/- 0.26 nmol transferred per mg protein in 30 min versus 3.32 +/- 0.56 for controls, P less than 0.025). Sialytransferase activities were not significantly different between diabetic and control rat livers. There were no significant differences between the diabetic and control rat liver microsomes in the activities of UDP N-acetylglucosamine pyrophosphatase, UDP galactose pyrophosphatase, or CMP sialic acid phosphatase. The glycosidases, N-acetylglucosaminidase and galactosidase, had similar activities in the livers of both groups of rats. Sialidase activity could not be detected in microsomal preparations from either diabetic or control rat livers. These results are discussed in relation to our previously reported alterations in glycosyltransferase activities, and plasma membrane glycoprotein composition in the livers of rats made insulin-resistant by a carbohydrate-free, high-fat diet and to the observation of Carter and his colleagues (FEBS Lett. 1979; 104:389-92.) that streptozotocin diabetes alters the glycoprotein composition of rat liver plasma membranes.

摘要

已研究链脲佐菌素诱导的糖尿病对大鼠肝脏糖基转移酶活性的影响。从3周前至2个月前静脉注射链脲佐菌素(65mg/kg)的大鼠制备肝脏微粒体部分。与年龄匹配的对照大鼠相比,糖尿病大鼠制备物中的N-乙酰葡糖胺基转移酶活性降低(30分钟内每毫克蛋白质转移0.98±0.11nmol,对照为3.19±0.34,P<0.001)。糖尿病大鼠肝脏中的半乳糖基转移酶活性也较低(30分钟内每毫克蛋白质转移1.48±0.26nmol,对照为3.32±0.56,P<0.025)。糖尿病和对照大鼠肝脏之间的唾液酸转移酶活性没有显著差异。糖尿病和对照大鼠肝脏微粒体在UDP-N-乙酰葡糖胺焦磷酸酶、UDP-半乳糖焦磷酸酶或CMP-唾液酸磷酸酶的活性方面没有显著差异。糖苷酶N-乙酰葡糖胺酶和半乳糖苷酶在两组大鼠肝脏中的活性相似。在糖尿病或对照大鼠肝脏的微粒体制备物中均未检测到唾液酸酶活性。结合我们先前报道的无糖、高脂肪饮食诱导胰岛素抵抗的大鼠肝脏中糖基转移酶活性和质膜糖蛋白组成的变化,以及Carter及其同事(FEBS Lett. 1979; 104:389-92.)观察到链脲佐菌素诱导的糖尿病改变大鼠肝脏质膜糖蛋白组成,对这些结果进行了讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验